NCT00318058View on ClinicalTrials.gov

Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population

PHASE1CompletedINTERVENTIONAL

Enrollment

84

Participants

Timeline

Start Date

October 3, 2005

Primary Completion Date

November 1, 2005

Study Completion Date

November 4, 2005

Conditions

Influenza

Interventions

BIOLOGICAL

influenza vaccine Fluarix, Adjuvanted Fluarix

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY